You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Klein Lawrence Otto · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$120.49K
Klein Lawrence Otto Chief Executive Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jun 15, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$68.86
Jun 15, 2026
First close after public filing
$67.71
Jun 16, 2026
30-day return after filing
+27.97%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,729 shares @ $69.69
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000062
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$120.49K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jun 15, 2026 | $120.49K |